Thursday, 18 April 2024
Trending

[the_ad_group id="2845"]

Business News

Issuing Royalty Certificates That Could Dilute Lanifibranor Earnings – TipRanks Financial Blog

Apellis downgraded to Hold at Jefferies after doctor survey

[the_ad id="21475"]

[ad_1]

Inventiva SA ADR (IVA) has disclosed a new risk, in the Share Price & Shareholder Rights category.

Inventiva SA ADR’s decision on August 30, 2023, to issue Royalty Certificates could potentially dilute future earnings from lanifibranor sales, as these certificates grant investors a 2% annual royalty. This financial commitment not only curtails Inventiva’s prospective revenue but also imposes a substantial repurchase cost that could strain the company’s cash reserves. Such fiscal obligations may devalue Inventiva’s market standing and adversely impact its overall financial health, posing a significant risk to both its business stability and shareholder returns.

The average IVA stock price target is $18.25, implying 401.37% upside potential.

To learn more about Inventiva SA ADR’s risk factors, click here.

Click Here to Read the Full Original Article at TipRanks Financial Blog…

[ad_2]

[the_ad id="21476"]